Showing 51-60 of 3129 results for "".
How Do You Manage the Aesthetic Patient?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-the-aesthetic-patient/18775/Managing the aesthetic patient is all about building relationships explains Joel L. Cohen, MD, founder of AboutSkin Dermatology in Englewood, CO. Dr. Cohen speaks with host Adam Friedman, MD, Associate Professor of Dermatology, Director, Residency Program, and Director, Translational Research at TheMeaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivAsk An Expert: Establishing Yourself as an Expert
https://practicaldermatology.com/topics/practice-management/ask-an-expert-establishing-yourself-as-an-expert/18937/In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's expertise, becoming an educator, and finding a comfortable place working with industry, peers, and societies. Whether your interest is in cosmetic dermatology, acne, psoriasis, pePhysician Spotlight: Mark D. Kaufmann, MD and Neal Bhatia, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-mark-d-kaufmann-md-and-neal-bhatia-md/23299/The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiAesthetics Update: A Q&A With Modern Aesthetics® editors Saami Khalifian, MD, and Kay Durairaj, MD, FACS
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetics-update-a-qa-with-modern-aesthetics-editors-saami-khalifian-md-and-kay-durairaj-md-facs/29203/The world of aesthetic medicine is rapidly evolving, from next-generation polynucleotides and biostimulators to shifts in patient demands and perceptions of beauty. To discuss the latest trends in aesthetics, Practical Dermatology® turned to its sister publication, Modern Aesthetics®, and new ChiefTerrence Keaney, MD, FAAD
https://practicaldermatology.com/topics/practice-management/terrence-keaney-md-faad/20644/Making the leap to private practice in 2017Julie Harper, MD, Reacts to New Report on Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/julie-harper-md-reacts-new-report-acne-products-benzoyl-peroxide-bpo/24172/In this video, Julie Harper, MD, a dermatologist with the Dermatology and Skin Care Center of Birmingham, AL, provides her thoughts on the recent Valisure report showing that some common acne products with benzoyl peroxide (BPO) may contain benzene. She says she’s been an “avid prescriber” of acne pHow Early Experience With PDT Can Provide Career Pathways
https://practicaldermatology.com/series/pdt-in-practice/how-early-experience-with-pdt-can-provide-career-pathways/20212/Adam Friedman, MD, professor and chair of dermatology at George Washington University, discusses how early-career experience with photodynamic therapy, including exposure to doctor-mentors in the field, gave him professional skills and connections that prepared him for later-career opportunities.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.